FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to pharmacology and clinical toxicology, and may be used for the prevention and correction of cytogenetic disorders. What is presented in a method for prevention and correction of cytogenetic disorders by using pharmacological products; what is prescribed is a low-molecular peptide preparation Glutoxim® in a dose of 30 mg/kg of laboratory animal's body weight.
EFFECT: presented method can provide a basis to develop the new methodological approaches to improving the effectiveness of the follow-up care and rehabilitation of the personnel involved in chemical weapon storage and destruction facilities.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OCCUPATIONAL SELECTION OF PERSONS FOR WORK ON DESTRUCTION OF CHEMICAL WARFARE AGENTS | 2016 |
|
RU2642603C2 |
| RADIOPROTECTIVE AGENT | 1997 |
|
RU2179020C2 |
| ANTIMUTAGENIC AGENT | 2000 |
|
RU2189232C2 |
| ANTIMUTAGEN | 2004 |
|
RU2266128C1 |
| PREPARATION OF ANTIMUTAGENIC ACTIVITY | 2004 |
|
RU2277417C1 |
| METHOD FOR ANTIMUTAGENIC EFFECT ON BODY | 2003 |
|
RU2261704C2 |
| METHOD OF ANTI-MUTAGENIC ACTION ON BODY | 1999 |
|
RU2145869C1 |
| METHOD OF ACTION ON BODY BY ANTIMUTAGENIC AGENT | 2010 |
|
RU2449780C1 |
| RADIOPROTECTIVE AGENT DIMINISHING RADIONUCLIDES ACCUMULATION | 0 |
|
SU1787032A3 |
| METHOD FOR DETECTING GENOMIC INSTABILITY IN CHILDREN WITH JUVENILE CEREBRAL PALSY | 2005 |
|
RU2295130C1 |
